from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1570/bioD

LFCtreatmentdescriptionclass of inhibitor

-0.964

Amikacinug/mL Amikacintranslation

-1.369

Cap5-10ug/mL Capreomycintranslation

-1.381

Rox10-50 ug/mL Roxithromycintranslation

-0.821

SM2-5 ug/mL Streptomycintranslation

-1.110

Tet5-10 ug/mL Tetracyclinetranslation

1.738

Rif0.2-5ug/mL Rifampicintranscription

-0.147

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.187

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.515

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.280

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.342

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.027

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.139

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.588

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.316

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.118

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.302

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.037

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.340

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.337

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.457

KCN5-20 ug/mL Potassium cyaniderespiration

0.064

NaN30.2-2 mM Sodium aziderespiration

-0.583

Nigericin50 uM Nigericinrespiration

0.032

TRC10-150 ug/mL Triclosanrespiration

-0.023

TRZ10-25 ug/mL Thioridazinerespiration

-0.507

Valinomycin0.5-10 uM Valinomycinrespiration

-2.039

ZnSO42 mM ZnSO4respiration

-0.279

menadione6-10 ug/mL Menadionerespiration

-0.827

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.927

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.464

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.524

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.217

NRP_1Non-replicating persistence stage 1dosRassociated

-0.035

Amp0.2mg/mL AmpicillincellWall

-0.753

Cephalexin20-100 ug/mL CephalexincellWall

-0.743

Cerulenin0.32-5 ug/mL CerulenincellWall

1.739

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.157

EMB10-20 ug/mL EthambutolcellWall

0.032

Eta12-40 ug/mL EthionamidecellWall

-0.395

INH0.2-0.4 ug/mL IsoniazidcellWall

0.708

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.838

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.543

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.889

BZA0.12 mg/mL BenzamidearomaticAmides

1.063

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.782

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.939

H2O24 mM hydrogen peroxideDNAdamaging

-1.085

Levo10 ug/mL LevofloxacinDNAdamaging

0.563

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.470

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.539

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.009

UVUV-irradiationDNAdamaging

0.087

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.559

Antimycin12.5-50 ug/mL Antimycin A?

-0.320

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.173

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.159

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.631

PA8240.2-2 ug/mL PA-824?

-0.841

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.320

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.414

Verapamil50 uM Verapamil?

0.424

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.927

methoxatin10-20 ug/mL Methoxatin?